丁纪元从虚、瘀、浊论治肿瘤相关性失眠经验介绍
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R249

基金项目:

浙江省中医药科技计划(2022ZA140)


Introduction of DING Jiyuan's Experience in Managing Cancer-Related Insomnia from Deficiency-Stasis-Turbidity Syndrome Differentiation
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    介绍丁纪元从虚、瘀、浊论治肿瘤相关性失眠的临床经验。丁纪元认为,肿瘤相关性失眠发病以 虚为病之本,瘀为病之标,浊为病之变,三者相互影响而发病。临证善于从虚、瘀、浊互结的动态病机出发, 常选太子参、黄芪、熟地黄三味药组成角药,以治气血虚之本;选桃仁、红花治疗瘀血阻滞之标;选半夏、陈 皮、白术配伍治疗痰浊蕴结之标。结合患者治疗经过、邪气偏盛、肿瘤类型及疾病阶段等四个因素,提出“四 因制宜”理念,辨病辨证结合,故能收获良效。

    Abstract:

    Abstract: This article introduces DING Jiyuan's clinical experience in treating cancer-related insomnia(CRI) from deficiency-stasis-turbidity syndrome differentiation.DING Jiyuan contends that CRI originates from deficiency as the root cause, manifests as stasis as the branch manifestation, and evolves through turbidity as the pathological transformation,with these three factors dynamically interacting to drive the disease.Clinically,he is adept at starting from the dynamic pathogenesis of the binding of deficiency,stasis and turbidity.He often uses three herbs,namely Pseudostellariae Radix, Astragali Radix, and Rehmanniae Radix Praeparata to treat the root cause as qi-blood deficiency.He uses Persicae Semen and Carthami Flos to treat the branch as blood stasis obstruction and stagnation, and he uses Pinelliae Rhizoma, Citri Reticulatae Pericarpium, and Atractylodis Macrocephalae Rhizoma to disperse phlegm-turbidity accumulation.Guided by the four-factor consideration principle,integrating the patient's treatment course, pathogen predominance, cancer type, and disease stage, DING's disease-syndrome integrated approach achieves significant clinical effect.

    参考文献
    相似文献
    引证文献
引用本文

张露馨,杨国良,张耀耀,徐玲,指导:丁纪元.丁纪元从虚、瘀、浊论治肿瘤相关性失眠经验介绍[J].新中医,2025,57(18):149-153

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-09-25
  • 出版日期:
文章二维码